RELAPSED/REFRACTORY

Clinical trials for RELAPSED/REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New CAR t-cell combo aims to control hard-to-treat leukemia

Disease control Recruiting now

This study tests whether a CAR T-cell drug called brexucabtagene autoleucel can safely control B-cell acute lymphoblastic leukemia (ALL) in adults whose cancer has returned or is high-risk. Participants first receive standard chemotherapy drugs, then the CAR T-cells. The goal is …

Matched conditions: RELAPSED/REFRACTORY

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 11, 2026 20:48 UTC

RELAPSED/REFRACTORY

Get alerted when new RELAPSED/REFRACTORY trials appear

New CAR t-cell combo aims to control hard-to-treat leukemia